Dominari Holdings Inc. financial data

Symbol
DOMH on Nasdaq
Location
725 Fifth Avenue, 22 Nd Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Aikido Pharma Inc. (to 12/21/2022), AIkido Pharma Inc. (to 12/21/2022), SPHERIX INC (to 3/13/2020), BIOSPHERICS INC (to 3/21/2001)
Latest financial report
10-K - Q4 2024 - Apr 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 915 % -51.8%
Debt-to-equity 14.1 % +66.4%
Return On Equity -35 % +7.49%
Return On Assets -30.7 % +12%
Operating Margin -63.5 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.6M shares +147%
Common Stock, Shares, Outstanding 6.98M shares +17.6%
Entity Public Float 7.75M USD -36.2%
Weighted Average Number of Shares Outstanding, Basic 6.18M shares +18.2%
Weighted Average Number of Shares Outstanding, Diluted 6.18M shares +18.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 18.1M USD
Research and Development Expense 2K USD -94.4%
General and Administrative Expense 29.7M USD +24.5%
Operating Income (Loss) -11.5M USD +47.1%
Nonoperating Income (Expense) -3.18M USD -192%
Net Income (Loss) Attributable to Parent -14.7M USD +35.7%
Earnings Per Share, Basic -2.38 USD/shares +45.7%
Earnings Per Share, Diluted -2.38 USD/shares +45.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.08M USD +44%
Marketable Securities, Current 5.77M USD -57.4%
Cash, Cash Equivalents, and Short-term Investments 13K USD
Assets, Current 28.2M USD +0.03%
Other Long-term Investments 20.9M USD
Property, Plant and Equipment, Net 239K USD -30.5%
Operating Lease, Right-of-Use Asset 2.94M USD -11.7%
Assets 47.1M USD -18.1%
Employee-related Liabilities, Current 177K USD -86.8%
Contract with Customer, Liability, Current 240K USD
Liabilities, Current 3.78M USD +135%
Contract with Customer, Liability, Noncurrent 860K USD
Operating Lease, Liability, Noncurrent 2.63M USD -13.2%
Liabilities 7.27M USD +56.9%
Retained Earnings (Accumulated Deficit) -223M USD -7.04%
Stockholders' Equity Attributable to Parent 39.9M USD -24.7%
Liabilities and Equity 47.1M USD -18.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.59M USD -115%
Net Cash Provided by (Used in) Financing Activities -939K USD -105%
Net Cash Provided by (Used in) Investing Activities 7.72M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 7.04M shares +17.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -23.6M USD -566%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.08M USD +44%
Deferred Tax Assets, Valuation Allowance 48.4M USD +0.88%
Deferred Tax Assets, Gross 49.3M USD +0.18%
Operating Lease, Liability 3.04M USD -11.9%
Depreciation 26K USD +271%
Payments to Acquire Property, Plant, and Equipment 361K USD
Lessee, Operating Lease, Liability, to be Paid 3.99M USD -15.5%
Property, Plant and Equipment, Gross 427K USD 0%
Operating Lease, Liability, Current 410K USD -2.61%
Lessee, Operating Lease, Liability, to be Paid, Year Two 685K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 698K USD -6.56%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 955K USD -25.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 685K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 35.9M USD +4.2%
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 766K USD +11.8%
Operating Lease, Payments 187K USD +450%
Additional Paid in Capital 264M USD +0.62%
Deferred Tax Assets, Net of Valuation Allowance 885K USD -27.5%
Share-based Payment Arrangement, Expense 300K USD +50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%